Gala Exceeds Fundraising Goals; Empowering Underserved RGV Cancer Patients 

Translate to Spanish or other 102 languages!

The Renaissance Cancer Foundation is delighted to announce that they surpassed their fundraising goal at the recent Ritmo en Fuego event. A total of $479,073 was raised and these monies will help the Foundation carry out vital services to underserved cancer patients in Hidalgo, Cameron, Starr, and Willacy Counties. Pictured from left to right are: Adriana Rios, Silent Auction Chairperson, Elizabet Bracamontes, Renaissance Cancer Foundation Clinical Director, David Deanda, Lone Star National Bank CEO and Platinum sponsor, Larry Safir, Renaissance Cancer Foundation Board Chairman, Marissa Castañeda, DHR Health Senior Executive Vice President, Dale Linebarger, Platinum sponsor, Diana and Juan Peña, Platinum sponsors, Natasha del Barrio, Bert Ogden & Fiesta Dealerships CEO and Platinum sponsor, Evelyn Saenz, Renaissance Cancer Foundation Executive Director, and Joel Garcia, Millennium Copier Systems CEO and Platinum sponsor. Courtesy Image
The Renaissance Cancer Foundation is delighted to announce that they surpassed their fundraising goal at the recent Ritmo en Fuego event. A total of $479,073 was raised and these monies will help the Foundation carry out vital services to underserved cancer patients in Hidalgo, Cameron, Starr, and Willacy Counties. Pictured from left to right are: Adriana Rios, Silent Auction Chairperson, Elizabet Bracamontes, Renaissance Cancer Foundation Clinical Director, David Deanda, Lone Star National Bank CEO and Platinum sponsor, Larry Safir, Renaissance Cancer Foundation Board Chairman, Marissa Castañeda, DHR Health Senior Executive Vice President, Dale Linebarger, Platinum sponsor, Diana and Juan Peña, Platinum sponsors, Natasha del Barrio, Bert Ogden & Fiesta Dealerships CEO and Platinum sponsor, Evelyn Saenz, Renaissance Cancer Foundation Executive Director, and Joel Garcia, Millennium Copier Systems CEO and Platinum sponsor. Courtesy Image
- Advertisement -

Edinburg, Texas: The Renaissance Cancer Foundation, a distinguished non-profit organization affiliated with DHR Health, proudly announced it surpassed its fundraising goal at the recent Ritmo en Fuego gala held on December 15, 2023 at the Edinburg Conference Center at Renaissance. This year’s event raised an impressive $479,073 that will continue to provide vital support for underserved cancer patients in Hidalgo, Cameron, Starr, and Willacy Counties.

Executive Director Evelyn Saenz expressed her gratitude for the collective efforts that led to the success of the event. She specifically acknowledged the event’s platinum sponsors, which included Bert Ogden Auto Group, DHR Health, Lone Star National Bank, Millennium Copier Systems and Supplies, Luby’s Culinary Services, Dale Linebarger and Family, and Juan and Diana Peña.

The annual gala is the non-profit’s signature fundraising event that enables the organization to fulfill its mission of assisting underserved cancer patients through a variety of ways including financial aid, transportation support, oncology wigs and more. This year’s gala featured a cocktail and hors d’oeuvres reception, a silent auction, and live music headlined by the multi-talented Republic of the Music band from San Diego, California. Post-gala festivities offered attendees the chance to “meet and greet” the band.

- Advertisement -

DHR Health Senior Executive Vice President Marissa Castaneda emphasized that the gala not only celebrates the Foundation’s mission but also secures essential funds for the upcoming year. For those interested in sponsoring opportunities for the next year’s gala, please contact Renaissance Cancer Foundation Executive Director via email at ev.saenz@dhr-rgv.com.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Dedicating Latest “South Texas Healthy Living” Episode to Arthritis Education, July 26th

More than 58 million U.S. adults are living with doctor-diagnosed arthritis, according to the Centers for Disease Control and Prevention (CDC), making it the nation’s leading cause of disability.

No More Needles: FDA Approves First Daily Pill to Replace Injectable Cholesterol Drugs

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH). Image source: Merck.com.

STHS Heart Ranks Among Nation’s Top Hospitals for Heart Attack Care

Every year, more than 800,000 people in the United States suffer a heart attack, according to the Centers for Disease Control and Prevention, an event that occurs approximately every 40 seconds.

DHR Health Burn Surgeon Urges Public to Avoid Preventable Risks

Many of the most serious burn and trauma injuries can be prevented by avoiding unnecessary risks, according to Dr. R. Dewayne Edwards, chief burn surgeon, surgical critical care and trauma surgeon at DHR Health, who said public awareness and timely medical care remain essential to improving patient outcomes.
- Advertisement -